Detection of collagenase-induced damage of collagen by 9A4, a monoclonal C-terminal neoepitope antibody

Matrix Biology

Volumn 18, Issue 4, 1999, Pages 331-341

  Otterness, Ivan G ^a   Downs, James T ^a   Lane, Caryl ^a   Bliven, Marcia L ^a   Stukenbrok, Hans ^a   Scampoli, Debra N ^a   Milici, A J ^a   Mézes, Peter S ^a  

^a Department of Cancer   (United States)

Author keywords

Cartilage failure; Collagen; Collagenase; Monoclonal antibody 9A4; Neoepitope antibody

Indexed keywords

COLLAGEN; COLLAGEN TYPE 2; COLLAGENASE; EPITOPE; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 9A4; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; BINDING KINETICS; CARBOXY TERMINAL SEQUENCE; COLLAGEN DEGRADATION; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; INFLAMMATION; KNEE ARTHRITIS; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DENATURATION; RUNNING; SCANNING ELECTRON MICROSCOPY; SURFACE PLASMON RESONANCE; SYRIAN HAMSTER;

ACUTE DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CARTILAGE, ARTICULAR; COLLAGEN; COLLAGENASES; CRICETINAE; EPITOPES; EXERTION; FEMALE; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MESOCRICETUS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; OSTEOCHONDRITIS; SURFACE PLASMON RESONANCE;

ANIMALIA; CRICETINAE;

EID: 0032764330     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(99)00026-8     Document Type: Article

References (40)

1. Beekman B., Drijfhout J.W., Bloemhoff W., Ronday H.K., Tak P.P., te Koppele J.M. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Lett. 390:1996;221-225.
2. Billinghurst R.C., Dahlberg L., Ionescu M. et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Invest. 99:1997;1534-1545.
3. Clark I.M., Powell L.K., Wright J.K., Cawston T.E., Hazleman B.L. Monoclonal antibodies against human fibroblast collagenase the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix. 12:1992;471-480.
4. Clark I.M., Powell L.K., Ramsey S., Hazleman B.L., Cawston T.E. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 36:1993;372-379.
5. 3H] acetylated collagen. Anal. Biochem. 148:1985;174-181.
6. Dean D.D., Martel-Pelletier J., Pelletier J.P., Howell D.S., Woessner J.F. Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84:1989;678-685.
7. Devarajan P., Mookhtiar K., Van Wart H., Berliner N. Structure and expression of the cDNA encoding human neutrophil collagenase. Blood. 77:1991;2731-2738.
8. Dodge G.R., Poole A.R. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin-1. J. Clin. Invest. 83:1989;647-661.
9. Dodge G.R., Pidoux I., Poole A.R. The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study. Matrix. 11:1991;330-338.
10. Firestein G.S., Paine M.M., Littman B.H. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement and HLA-DR) in rheumatoid and osteoarthritis synovium. Arthritis Rheum. 34:1991;1094-1105.
11. Gravallesse E.M., Darling J.M., Ladd A.L., Katz J.N., Glimcher L.H. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumaoid synovium. Arthritis Rheum. 34:1991;1076-1084.
12. Hasty K.A., Pourmotabbed T.F., Goldberg G.I. et al. Human neutrophil collagenase: a distinct gene product with homology to other matrix metalloproteinases. J. Biol. Chem. 265:1990;15862-15868.
13. Hodges R.S., Heaton R.J., Parker J.M.R., Molday L., Molday R.S. Antigen-antibody interaction. Synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin. J. Biol. Chem. 263:1988;11768-11775.
14. Hollander A.P., Heathfield T.F., Webber C. et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J. Clin. Invest. 93:1994;1722-1732.
15. Hollander A.P., Pidoux I., Reiner A., Rorabeck C., Bourne R., Poole A.R. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J. Clin. Invest. 96:1995;2859-2869.
16. Huebner J.L., Otterness I.G., Freund E.M., Caterson B., Kraus V.B. Collagenase 1 and collagenase 3 expression in a guinea pig model of osteoarthritis. Arthritis Rheum. 41:1998;877-890.
17. Kempson G.E. Age-related changes in the tensile properties of human articular cartilage: a comparative study between the femoral head of the hip joint and the talus of the ankle joint. Biochim. Biophys. Acta. 1075:1991;223-230.
18. Kempson G.E., Muir H., Pollard C., Tuke M. The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim. Biophys. Acta. 297:1973;465-472.
19. Kempson G.E., Tuke M.A., Dingle J.T., Barret A.J., Horsfield P.H. Biochim. Biophys. Acta. 428:1976;741-760.
20. Keyszer G.M., Heer A.H., Kriegsmann J. et al. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissue of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum. 38:1995;976-984.
21. Knight C.G., Willenbrook G., Murphy G. A novel coumarin-labeled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296:1992;263-266.
22. Maciewicz R.A., Wotton S.F., Etherington D.J., Duance V.C. Susceptibility of the cartilage collagens type II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L. FEBS Lett. 269:1990;189-193.
23. 2-terminal portion of the smaller fragment released from both collagens. Biochemistry. 15:1976;787-792.
24. Mitchell P.G., Magna H.A., Reeves L.M. et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97:1996;761-768.
25. Nieba L., Krebber A., Plückthun A. Competition BIAcore for measuring true affinities: Large differences from values determined from binding kinetics. Anal. Biochem. 234:1996;155-165.
26. Otterness I.G., Milici A.J., Bliven M.L. Some factors affecting inhibition and restoration of mobility after induction of an acute arthritis in the hamster. Agents Actions. 40:1993;224-227.
27. Otterness I.G., Bliven M.L., Milici A.J., Poole A.R. Comparison of mobility changes with histologic and biochemical changes during lipopolysaccharide-induced arthritis in the hamster. Am. J. Pathol. 144:1994;1098-1108.
28. Otterness I.G., Eskra J.D., Bliven M.L., Shay A.K., Pelletier J.-P., Milici A.J. Exercise is required to maintain articular cartilage integrity in the hamster. Arthritis Rheum. 41:1998;2068-2076.
29. Pelletier J.-P., Martel-Pelletier J., Althman R.D., Ghandur-Mnaymneh L., Enis J.E., Woessner J.F. Jr. Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum. 26:1983;63-68.
30. BIAapplications Handbook. Pharmacia Biosensor. 1994;51-512 Uppsala, Sweden.
31. Radin E.L., Rose R.M. The role of subchondral bone in the initiation and progression of cartilage damage. Clin. Orthop. Rel. Res. 213:1986;34-40.
32. Radin E.L., Marin R.B., Burr D.B., Caterson B., Boyd R.D., Goodwin D. Effects of mechanical loading on the tissues of the rabbit knee. J. Orthop. Res. 2:1984;221-234.
33. Reboul P., Pelletier J.P., Tardif G., Cloutier J.M., Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J. Clin. Invest. 97:1996;2011-2019.
34. Schmidt M.B., Mow V.C., Chun L.E., Eyre D.R. Effects of proteoglycan extraction on the tensile behavior of articular cartilage. J. Orthop. Res. 8:1990;353-363.
35. Shay A.K., Bliven M.L., Scampoli D.N., Otterness I.G., Milici A.J. Effects of exercise on synovium and cartilage from normal and inflamed knees. Rheum. Int. 14:1995;183-189.
36. Srinivas G.R., Barrach H.J., Chichester C.O. Quantitative immunoassays for type II collagen and its cyanogen bromide peptides. J. Immunol. Meth. 159:1993;53-62.
37. Srinivas G.R., Chichester C.O., Barrach H.J., Pillai V., Matoney A.L. Production of type II collagen specific monoclonal antibodies. Immunol. Invest. 23:1994;85-98.
38. 2F suppresses digestion of collagen by fibroblasts and osteoclasts. Biochem. Biophys. Res. Commun. 178:1991;178-184.
39. Vankemmekbeke M., Dekeyser P.M., Hollander A.P., Buttle D.J., Demeester J. Characterization of helical cleavages in type II collagen generated by matrixins. Biochem. J. 330:1998;633-640.
40. Whitham S.M., Murphy G., Angel P. et al. Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem. J. 240:1986;913-916.